Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Animal Drug Compounding Market

Animal Drug Compounding Market Size

  • Report ID: GMI10492
  • Published Date: Jul 2024
  • Report Format: PDF

Animal Drug Compounding Market Size

Animal Drug Compounding Market size was valued at USD 2.2 billion in 2023 and is estimated to grow at 8.3% CAGR from 2024 to 2032. The market has seen substantial growth due to the increasing prevalence of chronic diseases among pets and livestock animals which has increased the emphasis on personalized veterinary care.

 

Chronic diseases such as arthritis, diabetes, cancer, and other diseases are anticipated to significantly increase the demand for tailored medication solutions that standard pharmaceuticals often fail to provide. This trend towards personalized veterinary care is fostering a greater reliance on compounded drugs to meet the diverse needs of animals further bolstering the market growth.
 

In addition, global pet ownership continues to grow, owners are becoming more attuned to their pets' specific health requirements, driving the need for customized medications that effectively address these unique conditions, further propelling market growth.
 

Animal drug compounding is the process of creating customized drugs for animals by combining, mixing, or altering ingredients to meet specific health needs. This practice is essential when commercially available drugs do not adequately address an animal's unique condition, dosage requirements, or formulation preferences. Compounded medications can include tailored dosages, flavors, or forms (such as liquids or gels) to enhance palatability and compliance.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The animal drug compounding industry size was valued at USD 2.2 billion in 2023 and will grow at 8.3% CAGR from 2024 to 2032 due to increasing prevalence of chronic diseases among pets and livestock animals

The oral segment in the animal drug compounding industry is projected to record 8.1% CAGR during 2024-2032, as they are more palatable and can be easily customized to suit individual animal needs, enhancing compliance.

U.S. animal drug compounding market size was USD 1.3 billion in 2023 led by high pet ownership rates and substantial R&D investments

AVRIO Pharmacy, New Era Pharmacy, NexGen Pharmaceuticals, Pace Pharmacy, SaveWay Compounding Pharmacy, ScriptWorks, SCIRx Pharmacy, Summit Veterinary Pharmacy Ltd., and Triangle Compounding Pharmacy

Animal Drug Compounding Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 373
  • Countries covered: 22
  • Pages: 170
 Download Free Sample